Post-abortion complications after interruption of pregnancy with misoprostol

@article{Fandes1996PostabortionCA,
  title={Post-abortion complications after interruption of pregnancy with misoprostol},
  author={An{\'i}bal Fa{\'u}ndes and L Cardoso Santos and M. Carvalho and Clemens Gras},
  journal={Advances in Contraception},
  year={1996},
  volume={12},
  pages={1-9}
}
The high incidence of abortion in Brazil and the increased use of misoprostol among women having clandestine/unsafe abortions has led to an interest in evaluating whether there is an association between the use of misoprostol and the incidence of septic complications post-abortion. To test this association, a retrospective cohort study was conducted with 1840 women treated post-abortion at the Instituto Materno-Infantil de Pernambuco (IMIP) between 1988 and 1992. Incidence of infection (4.2… Expand
Commercial availability of misoprostol and induced abortion in Brazil
  • S. H. Costa
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 1998
TLDR
The experience of Brazilian women with misoprostol is an example of how women when faced with unwanted pregnancy will resort to illegal abortion whatever the costs are to their health. Expand
Artificial abortion: is reduction in the frequency and severity of complications a result of the use of misoprostol?
TLDR
The data show a reduction in the frequency and severity of complications arising from abortion, although it is not possible to point to the use of misoprosol as being responsible for this. Expand
Use of Misoprotol to induce abortion up to 9 weeks
TLDR
The results suggest that the administration of a dose of 800 μg of Misoprostol every 8 hours by vaginal route is an adequate method to interrupt pregnancy between the 6 and 9 weeks of gestation. Expand
Building Bridges: A Case for Community Health Worker Provision of Misoprostol-Only Abortion in the First Trimester.
TLDR
This study demonstrates that community health workers are able to provide misoprostol-only abortion services to women effectively and safely and also extends beyond the abortion service to offer women a comprehensive range of quality health services, including contraceptive services, increasing access to vital healthcare in areas with few other options. Expand
[Illegal abortion with misoprostol in Guadeloupe].
TLDR
The profile of the population concerned and the justifications for choosing illegal abortion by misoprostol provides elements allowing better focus of education concerning abortion, contraception and family planning. Expand
Termination of pregnancy and unsafe abortion.
  • L. Lim, Kuldip Singh
  • Medicine
  • Best practice & research. Clinical obstetrics & gynaecology
  • 2014
TLDR
Clinical guidelines should be available in all healthcare sectors providing abortion services to ensure a uniformly high standard of care for all women requesting abortions and services should ensure that written, objective, evidence-guided information is available for women considering abortion to take away before the procedure, including complications and sequelae of abortion. Expand
Misoprostol in obstetrics and gynecology
  • A. Weeks, A. Faúndes
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 2007
TLDR
Misoprostol is an analogue of prostaglandin E1 which was registered in many countries during the second half of the 1980s under the proprietary name Cytotec (Pharmacia), for the treatment of peptic ulcers, particularly those caused by non-steroidal anti-inflammatory drugs. Expand
Use of misoprostol in first and second trimester abortion: a review.
TLDR
The use of misoprostol as an abortifacient has, however, not been supported by the manufacturer, which leads to the situation that it is used and researched, but probably will not be officially approved for this specific indication. Expand
Misoprostol use and its impact on measuring abortion incidence and morbidity.
Misoprostol is an effective and increasingly popular medication abortion option especially in developing countries where abortion remains legally restricted. Taking a pill is noninvasive and theExpand
Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy
  • A. Faúndes, C. Fiala, O. Tang, A. Velasco
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 2007
TLDR
The experience on pregnancy termination between 10 and 12 weeks is not yet sufficient for a recommendation, but the oral and sublingual routes appear to be better accepted than vaginal administration. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 14 REFERENCES
Misoprostol and illegal abortion in Fortaleza, Brazil
TLDR
The records of women admitted to the main obstetric hospital of Fortaleza between January, 1990, and July, 1992, for uterine evacuation after induced abortion were reviewed, finding that the number of incomplete abortions induced by misoprostol increased substantially during the first half of1990, and declined thereafter. Expand
Misoprostol and illegal abortion in Rio de Janeiro, Brazil
TLDR
The likelihood of bleeding starting within 12 h of administration increased with duration of gestation and it was greater when the drug was used both orally and intravaginally, and misoprostol has an important role as an abortifacient among the women studied. Expand
Misoprostol: the experience of women in Fortaleza, Brazil.
TLDR
Despite the current lack of safer alternatives, misoprostol does not seem a satisfactory solution to illegal abortion in Brazil. Expand
The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy.
TLDR
Intravaginal misoprostol, a PGE2 methyl-analogue, was used by 169 women whose request for interruption of pregnancy had been approved and successfully induced in 154 women, and curettage was performed in all but one of such cases. Expand
A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy.
TLDR
Misoprostol is at least as effective as PGE2 for the termination of second-trimester pregnancy involving either a dead or a living fetus, but it is less costly, is easier to administer, and is associated with fewer adverse effects. Expand
Induction of labor with intravaginal misoprostol in intrauterine fetal death.
TLDR
Intravaginal misoprostol at the dose of 100 micrograms every 12 hours appears to be a safe, effective, practical, and inexpensive new method for induction of labor in intrauterine fetal death. Expand
Low‐dose vaginal misoprostol for induction of labor with a live fetus
TLDR
Vaginal misoprostol, in very low doses, was a remarkably efficient and safe method for induction of labor with a live fetus. Expand
Intravaginal Misoprostol Versus Dinoprostone As Cervical Ripening and Labor-Inducing Agents
TLDR
Misoprostol is as effective as dinoprostone for inducing labor at term and there were no significant differences in induction-to-delivery interval, spontaneous labor rates, type of delivery, fetal outcome, or maternal complications. Expand
Labor induction with the prostaglandin E1 methyl analog misoprostol versus oxytocin: A randomized trial
TLDR
Clinical trials appear warranted to detail misoprostol's optimal route, dose, and schedule for labor induction and its safety, and the use of PGE2 gel for cervical ripening contributed to the longer induction‐to‐vaginal delivery interval noted in the oxytocin group. Expand
The Brazilian experience with Cytotec.
TLDR
Analysis of the drug's sales profile, of information published by the media, and of its use from women's and gynecologists' points of view show that Cytotec's addition to the obstetric therapeutic arsenal was welcome and also confirmed theDrug's influence in reducing the complications of illegal abortions shown in other studies. Expand
...
1
2
...